Chemical Engineering of Therapeutic siRNAs for Allele-Specific Gene Silencing in Huntington’s Disease Models

By utilizing Huntington’s disease models, researchers optimized siRNA compounds that exhibited selective silencing of mutant huntingtin proteins in patient-derived cells, demonstrating SNP-based allele-specific RNAi silencing of gene expression in vivo in the central nervous system.